Template:Isosorbide mononitrate: Difference between revisions

Latest revision as of 03:09, 31 January 2014

Isosorbide mononitrate
ISOSORBIDE MONONITRATE tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

@@ Line 17: / Line 17: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate drug interactions|Drug Interactions]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate use in specific populations|Use in Specific Populations]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate overdosage|Overdosage]]
@@ Line 25: / Line 23: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate clinical pharmacology|Clinical Pharmacology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate nonclinical toxicology|Nonclinical Toxicology]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Isosorbide mononitrate clinical studies|Clinical Studies]]